Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:04 pm Sale | 13G | WEREWOLF THERAPEUTICS INC HOWL | PFM Health Sciences LP | 3,398,747 7.800% | -69,430 (-2.00%) | View |
| 2024-11-14 11:54 am Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | BANK OF AMERICA CORP BAC | 2,157,395 4.900% | 61,314 (+2.93%) | View |
| 2024-11-13 4:30 pm Sale | 13G | WEREWOLF THERAPEUTICS INC HOWL | Rubric Capital Management LP | 1,333,893 3.050% | -601,464 (-31.08%) | View |
| 2024-11-12 09:37 am Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | Adage Capital Management L.P. | 2,000,594 4.580% | 2,000,594 (New Position) | View |
| 2024-05-07 4:52 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 6,192,881 14.200% | 13,846 (+0.22%) | View |
| 2024-02-14 5:17 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 6,179,035 15.200% | 19,981 (+0.32%) | View |
| 2024-02-14 4:06 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | PFM Health Sciences LP | 3,468,177 9.600% | 1,646,357 (+90.37%) | View |
| 2024-02-13 6:58 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | BANK OF AMERICA CORP BAC | 2,096,081 5.800% | 2,096,081 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | Rubric Capital Management LP | 1,935,357 5.350% | 99,970 (+5.45%) | View |
| 2023-12-21 4:30 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,034,255 8.380% | 3,034,255 (New Position) | View |
| 2023-02-10 4:00 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | Rubric Capital Management LP | 1,835,387 5.970% | 1,835,387 (New Position) | View |
| 2023-01-17 4:01 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | PFM Health Sciences LP | 1,821,820 5.300% | 528,527 (+40.87%) | View |
| 2023-01-17 1:20 pm Sale | 13G | WEREWOLF THERAPEUTICS INC HOWL | PFM Health Sciences LP | 1,293,293 4.200% | -223,733 (-14.75%) | View |
| 2023-01-10 5:11 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 6,159,054 17.960% | 1,854,607 (+43.09%) | View |
| 2022-08-12 4:32 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 4,304,447 14.570% | 12,566 (+0.29%) | View |
| 2022-05-02 4:02 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | PFM Health Sciences LP | 1,517,026 5.500% | 1,517,026 (New Position) | View |
| 2022-02-11 4:11 pm Sale | 13G | WEREWOLF THERAPEUTICS INC HOWL | Flynn James E | 958,125 3.470% | -1,594,662 (-62.47%) | View |
| 2021-06-16 4:59 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 4,291,881 15.600% | 323,298 (+8.15%) | View |
| 2021-05-14 5:18 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | MPM BioVentures 2014 L.P. | 6,731,087 24.400% | 6,731,087 (New Position) | View |
| 2021-05-14 4:42 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | Longwood Fund III GP LLC | 1,677,082 6.100% | 1,677,082 (New Position) | View |